We offer tfour equity investment strategies: a U.S. Small-Capitalization, a Merger-Arbitrage event-driven strategy a passively managed Small-cap Biotech+ , and a passively managed Junior Biotech+ strategy. All strategies are offered in Separate Account format.

*Please note that Expected Excess Returns (a) are not a guarantee of performance and (b) will include reinvestment of dividends and other earnings.